Teladoc beats Wall Street expectations in Q2 amid strategic revamp

Still, the virtual care giant reported revenue and earnings decline at BetterHelp, Teladoc’s direct-to-consumer mental health segment that has faced challenges for several quarters.

Still, the virtual care giant reported revenue and earnings decline at BetterHelp, Teladoc’s direct-to-consumer mental health segment that has faced challenges for several quarters.

The company raised its outlook as many insurers are struggling with elevated medical costs in the second quarter.

More than 60 companies, including Amazon, Google, UnitedHealth and Epic, have pledged to participate in the initiative, which the CMS said would “deliver results” early next year.

The American Medical Association’s research, which found that local PBM markets are highly concentrated, is more fuel for critics of the powerful drug middlemen.

In light of the results, executives backed away from prior behavioral health growth targets for 2025, though they slightly raised the midpoint of overall revenue guidance.

The Kentucky-based company’s results are a bright spot in what’s otherwise been a gloomy quarter for health insurers. Humana says it has a handle on snowballing medical costs after taking a conservative stance heading into the year.

The average monthly bid submitted by insurers for 2026 prescription drug plans increased 33% from last year, according to data released by the CMS.
Prasad’s exit ends a tumultuous tenure during which he led a reworking of agency guidelines on COVID vaccines and his office got embroiled in controversy over a Duchenne gene therapy.
Steve Collis’ three decades of experience at a major drug distributor could prove helpful for Elevance as it continues to build out its pharmacy services.

U.S. District Judge Brian Miller agreed with pharmacy benefit managers that the state’s law may violate the Constitution in granting their request for a preliminary injunction.